Diskussionsleiter: W. Schöls (Duisburg)
| (P513) | High prevalence of typical atrial flutter in patients with atypical electrocardiogram | |
| K. Petscher, L. Winter, A. Pott, W. Rottbauer, T. Dahme (Ulm) | ||
| (P514) | Correlation of IGF-1 and IGF-1/IGFBP-3 with prevalent and incident atrial fibrillation in a population-based study | |
| A. Krüger, S. Groß, T. Ittermann, N. Friedrich, M. Nauck, M. Dörr, S. B. Felix, M. Busch, für die Studiengruppe: SHIP (Greifswald) | ||
| (P515) | Clinical characteristics and 1-year outcome of patients receiving an implantable cardioverter defibrillator for syncope and inducible ventricular tachycardia. Results from the German Device Registry | |
| S. Liosis, D. Andresen, T. Kleemann, S. G. Spitzer, J. Brachmann, C. Stellbrink, L. Eckardt, B.-D. Gonska, E. Hoffmann, K.-H. Kuck, M. Hochadel, J. Senges, R. R. Tilz (Lübeck, Berlin, Ludwigshafen am Rhein, Dresden, Coburg, Bielefeld, Münster, Karlsruhe, München, Hamburg) | ||
| (P516) | Differences in Catheter Ablation of Supraventricular Tachycardia according to underlying Heart Disease: Insights from the German Ablation Registry | |
| C. Eitel, H. Ince, J. Brachmann, K.-H. Kuck, S. Willems, S. G. Spitzer, J. Tebbenjohanns, F. Straube, M. Hochadel, J. Senges, R. R. Tilz (Lübeck, Berlin, Coburg, Hamburg, Dresden, Hildesheim, München, Ludwigshafen am Rhein) | ||
| (P517) | The diagnostic role of the ECG in the prevention of SCD in female elite ice hockey players – Results from the "General Program for Prevention of Arrhythmia Related Death in Athletes" (GEPARD) | |
| S. Muxel, M. Berr, M. Berger, U. Platz, S. Hartl, B. Brück, U. Dorwarth, F. Straube, E. Hoffmann (München) | ||
| (P518) | The role of HDL in AF patients: association with APPLE score | |
| J. Kornej, M. Trieb, G. Marsche, G. Hindricks, P. Büttner (Leipzig; Graz, AT) |